256 related articles for article (PubMed ID: 31680765)
1. Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists.
Park JY; Chae S; Kim CS; Kim YJ; Yi HJ; Han E; Joo Y; Hong S; Yun JW; Kim H; Shin KH
Korean J Physiol Pharmacol; 2019 Nov; 23(6):427-448. PubMed ID: 31680765
[TBL] [Abstract][Full Text] [Related]
2. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
3. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
Gavioli EC; Calo' G
Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
[TBL] [Abstract][Full Text] [Related]
4. Nociceptin/orphanin FQ peptide receptor mediates inhibition of N-type calcium currents in vestibular afferent neurons of the rat.
Seseña E; Soto E; Bueno J; Vega R
J Neurophysiol; 2020 Dec; 124(6):1605-1614. PubMed ID: 32966754
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands.
Gavioli EC; Calo' G
Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):319-30. PubMed ID: 16491387
[TBL] [Abstract][Full Text] [Related]
6. Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related Disorders.
Ubaldi M; Cannella N; Borruto AM; Petrella M; Micioni Di Bonaventura MV; Soverchia L; Stopponi S; Weiss F; Cifani C; Ciccocioppo R
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884757
[TBL] [Abstract][Full Text] [Related]
7. Nociceptin/orphanin FQ neurons in the Arcuate Nucleus and Ventral Tegmental Area Act via Nociceptin Opioid Peptide Receptor Signaling to Inhibit Proopiomelanocortin and A
Hernandez J; Perez L; Soto R; Le N; Gastelum C; Wagner EJ
Physiol Behav; 2021 Jan; 228():113183. PubMed ID: 32979341
[TBL] [Abstract][Full Text] [Related]
8. Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test.
Gavioli EC; Marzola G; Guerrini R; Bertorelli R; Zucchini S; De Lima TC; Rae GA; Salvadori S; Regoli D; Calo G
Eur J Neurosci; 2003 May; 17(9):1987-90. PubMed ID: 12752799
[TBL] [Abstract][Full Text] [Related]
9. NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine.
Holanda VAD; Santos WB; Asth L; Guerrini R; Calo' G; Ruzza C; Gavioli EC
Psychopharmacology (Berl); 2018 Nov; 235(11):3093-3102. PubMed ID: 30145654
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands.
Viaro R; Calcagno M; Marti M; Borrelli E; Morari M
Neuropharmacology; 2013 Sep; 72():126-38. PubMed ID: 23643745
[TBL] [Abstract][Full Text] [Related]
11. The Nociceptin/Orphanin FQ System and the Regulation of Memory.
Moulédous L
Handb Exp Pharmacol; 2019; 254():259-278. PubMed ID: 30430261
[TBL] [Abstract][Full Text] [Related]
12. GIRK channel-mediated inhibition of melanin-concentrating hormone neurons by nociceptin/orphanin FQ.
Parsons MP; Hirasawa M
J Neurophysiol; 2011 Mar; 105(3):1179-84. PubMed ID: 21191090
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of nociceptin/orphanin FQ peptide (NOP) receptor modulators for treatment of traumatic brain injury, traumatic stress, and their co-morbidities.
Al Yacoub ON; Awwad HO; Zhang Y; Standifer KM
Pharmacol Ther; 2022 Mar; 231():107982. PubMed ID: 34480968
[TBL] [Abstract][Full Text] [Related]
14. Nociceptin/orphanin FQ acts as a functional antagonist of corticotropin-releasing factor to inhibit its anorectic effect.
Ciccocioppo R; Cippitelli A; Economidou D; Fedeli A; Massi M
Physiol Behav; 2004 Aug; 82(1):63-8. PubMed ID: 15234592
[TBL] [Abstract][Full Text] [Related]
15. Nociceptin/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress.
Gavioli EC; Holanda VAD; Calo G; Ruzza C
Peptides; 2021 Jul; 141():170548. PubMed ID: 33862163
[TBL] [Abstract][Full Text] [Related]
16. Blockade of nociceptin/orphanin FQ signaling facilitates an active copying strategy due to acute and repeated stressful stimuli in mice.
Holanda VAD; Oliveira MC; Da Silva Junior ED; Calo' G; Ruzza C; Gavioli EC
Neurobiol Stress; 2020 Nov; 13():100255. PubMed ID: 33344710
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol-rich lipid rafts are involved in neuropeptide FF anti-nociceptin/orphanin FQ effect.
Ding Z; Zajac JM
J Neurochem; 2016 Feb; 136(4):778-790. PubMed ID: 26617404
[TBL] [Abstract][Full Text] [Related]
18. Nociceptin/orphanin FQ and the regulation of neuronal excitability in the rat bed nucleus of the stria terminalis: interaction with glucocorticoids.
Dawe KL; Wakerley JB; Fulford AJ
Stress; 2010 Nov; 13(6):516-27. PubMed ID: 20666662
[TBL] [Abstract][Full Text] [Related]
19. CompB (J-113397), selectively and competitively antagonizes nociceptin activation of inwardly rectifying K(+) channels in rat periaqueductal gray slices.
Chiou LC; Fan SH
Neuropharmacology; 2002 Jun; 42(7):987-92. PubMed ID: 12069909
[TBL] [Abstract][Full Text] [Related]
20. The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus.
D'Oliveira da Silva F; Azevedo Neto J; Sturaro C; Guarino A; Robert C; Gavioli EC; Calo G; Mouledous L; Ruzza C
Neuropharmacology; 2022 Jul; 212():109077. PubMed ID: 35513173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
